To confirm our sequencing data, reverse transcription-quantitative PCR was utilized for measuring MEX3D mRNA expression levels in an additional cohort of 25 normal cervical tissues and 38 human cervical cancer tissues. This evidence concerns the gene MEX3D and cervical cancer.